Regulus filed a solicitation/recommendation statement on Schedule 14D-9 with the SEC, which includes, among other things, the recommendation of Regulus’s board of directors that Regulus’s stockholders ...

Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced ...

Shares of Predictive Oncology Inc. (POAI) fell to their lowest level in a month on Thursday, drawing significant retail attention. Renovaro announced that its 2025 lawsuit to enforce a merger ...

Renovaro Inc. (NASDAQ:RENB) stated that the Delaware Court of Chancery has granted an expedited trial to its action against ...

One of the biggest deals of the year so far started around Valentine’s Day, with a love letter. Chris Winfrey, the chief ...

A key objective outlined in Commissioner Ribera’s mission letter is the modernization of EU competition policy, including the framework employed ...